Neptune Technologies & Bioressources Company Profile (TSE:NTB)

About Neptune Technologies & Bioressources

Neptune Technologies & Bioressources logoNeptune Technologies & Bioressources Inc. is a solution provider of omega-3's and other functional ingredients to branded marketers in the nutraceutical industry, primarily in North America. The Company is engaged in the development, manufacture and commercialization of marine-derived omega-3 fatty acids. The Company's products include Krill-Based Nutraceutical Products, including Neptune Krill Oil (NKO), OCEANO3, Formulations Derived from NKO and Neptune Krill Aquatein (NKA); Other Nutraceutical Products, and Pharmaceutical Product Candidate (CaPre)-Acasti. The Company's NKO is a marine oil extracted from krill (Euphasia superba). NKO consists of phospholipids, which contain omega-3 fatty acids, including eicosapentaenoic acid and docosahexaenoic acid (EPA & DHA), and antioxidants, such as astaxanthin, vitamin A and vitamin E. The Company sells OCEANO3 directly to consumers in Canada through its online platform (, under its brand name.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: TSE
  • Symbol: NTB
  • CUSIP:
Key Metrics:
  • Previous Close: $1.36
  • 50 Day Moving Average: $1.29
  • 200 Day Moving Average: $1.35
  • 52-Week Range: C$1.08 - C$1.75
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $108.34M
  • Outstanding Shares: 77,945,000
Additional Links:

Analyst Ratings

Consensus Ratings for Neptune Technologies & Bioressources (TSE:NTB) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Neptune Technologies & Bioressources (TSE:NTB)
No equities research coverage for this company has been tracked by


Earnings History for Neptune Technologies & Bioressources (TSE:NTB)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/16/2014($0.08)($0.06)ViewN/AView Earnings Details
5/22/2014($0.08)($0.08)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Neptune Technologies & Bioressources (TSE:NTB)
Current Year EPS Consensus Estimate: $0.01 EPS


Dividend History for Neptune Technologies & Bioressources (TSE:NTB)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Neptune Technologies & Bioressources (TSE:NTB)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/1/2016James Stuart HamiltonDirectorBuy4,000C$1.58C$6,320.00
1/28/2016James Stuart HamiltonDirectorBuy2,000C$1.55C$3,100.00
1/18/2016Mario ParadisInsiderBuy10,000C$1.50C$15,000.00
1/15/2016John Morris MoretzDirectorBuy700,651C$1.05C$735,683.55
1/15/2016Mario ParadisInsiderBuy40,000C$1.54C$61,672.00
10/29/2015John Morris MoretzDirectorBuy26,044C$1.08C$28,101.48
10/28/2015John Morris MoretzDirectorBuy24,500C$1.12C$27,538.00
10/27/2015John Morris MoretzDirectorBuy5,500C$1.09C$6,006.00
10/23/2015John Morris MoretzDirectorBuy50,000C$1.17C$58,385.00
10/5/2015John Morris MoretzDirectorBuy13,692C$1.24C$16,991.77
10/2/2015John Morris MoretzDirectorBuy33,900C$1.23C$41,663.10
9/15/2015John Morris MoretzDirectorBuy9,001C$1.24C$11,161.24
7/22/2015John Morris MoretzDirectorBuy2,800C$1.34C$3,750.60
7/21/2015John Morris MoretzDirectorBuy21,654C$1.34C$28,975.22
7/16/2015Pierre LemieuxDirectorSell6,250C$1.62C$10,135.00
6/8/2015Pierre FitzgibbonDirectorBuy47,500C$1.70C$80,693.00
2/17/2015Reed TucksonDirectorBuy10,800C$1.85C$19,931.40
2/13/2015Michel TimperioInsiderSell10,000C$2.19C$21,870.00
2/6/2015André GodinInsiderSell5,000C$2.14C$10,700.00
2/5/2015Michel TimperioInsiderSell15,000C$2.11C$31,680.00
1/30/2015Bel Dominique LeInsiderSell15,000C$2.30C$34,500.00
1/29/2015Bel Dominique LeInsiderSell10,000C$2.25C$22,500.00
1/22/2015Claudie LauzonInsiderSell8,334C$2.04C$16,966.36
1/22/2015Pierre LemieuxDirectorSell11,250C$2.00C$22,500.00
(Data available from 1/1/2013 forward)


Latest Headlines for Neptune Technologies & Bioressources (TSE:NTB)
News IconNeptune to Hold Conference Call to Discuss Second Quarter Results for the Period Ended August ... (TSE:NTB) - September 28 at 6:13 PM logoNeptune Technologies & Bioressources : to Hold Conference Call to Discuss Second Quarter Results FY2017 (TSE:NTB) - September 28 at 6:13 PM
News IconInnovative Krill Oil Product with one of the Highest Concentration of Omega-3s (TSE:NTB) - September 16 at 9:59 AM logoNEPTUNE Introduces NKO® Omega Plus, a New and Innovative Krill Oil Product with one of the Highest Concentration of Omega-3s (TSE:NTB) - September 16 at 9:59 AM logoFiscal Year 2017 Brings New Krill Oil Development (TSE:NTB) - August 8 at 6:43 PM logoAcasti Announces the Election of its Directors, Change of Fiscal Year End and Other Related Matters Passed at its AGM (TSE:NTB) - July 15 at 12:26 PM logoEdited Transcript of NTB.TO earnings conference call or presentation 12-Jul-16 12:00pm GMT (TSE:NTB) - July 12 at 11:48 AM
News IconGeneral Mills Inc said late Monday it is recalling one of its Betty Crocker brand cake mixes from Canadian markets because of a possible E (TSE:NTB) - July 12 at 10:50 AM logoNeptune Announces First Quarter Results (TSE:NTB) - July 12 at 10:50 AM logoNeptune Announces First Quarter Results / Record Revenues and EBITDA for the Quarter in the Nutraceutical Segment (TSE:NTB) - July 11 at 6:31 PM logoNeptune Technologies & Bioressources : Announces First Quarter Results (TSE:NTB) - July 11 at 6:31 PM logoQ1 2017 Neptune Technologies & Bioressources Inc Earnings Release - After Market Close (TSE:NTB) - July 11 at 7:07 AM


Neptune Technologies & Bioressources (TSE:NTB) Chart for Thursday, September, 29, 2016

Last Updated on 9/29/2016 by Staff